HSPA5 and breast carcinoma: To validate our assumption, the results of CCK-8 and clonogenic assays demonstrated that GRP78 overexpression improved the survival of taxol-treated breast cancer cells in a time- and dose-dependent manner, while GRP78 silencing apparently inhibited cell proliferation of taxol-treated breast cancer cells compared to the control group (Figures 5B,C).